Caribou Biosciences, Inc.

NASDAQ:CRBU

1.8 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -34.684-37.697-41.234-34.505-10.002-29.519-28.044-26.989-26.647-26.697-19.088-18.479-20.974-14.311-13.159-14.703-7.933-1.872-9.8
Depreciation & Amortization 1.1770.8560.711.9741.5790.6170.5890.5060.450.3580.3080.2730.260.230.2210.220.2260.2280.226
Deferred Income Tax 000-5.496-2.44-2.1260-0.0950000.3210-1.5780.00300.0700.733
Stock Based Compensation 4.0694.7383.9883.5563.4783.5853.1313.1012.6732.9183.0241.5780.9350.5930.3430.2310.2480.2860.237
Change In Working Capital -2.0122.861-0.8495.024-22.06912.089-2.362-0.128-0.7071.739-5.108-2.6562.409-2.90132.2150.81-1.2221.653-1.064
Accounts Receivables 0.2070.6970.2451.278-0.3670.767-1.3310.1950.127-0.150.779-0.575-0.5760.0740.074-0.150.0210.012-0.029
Change In Inventory 000-5.2730.8194.45400000-1.9254.119-6.5422.148-1.1111.3640.440.662
Change In Accounts Payables -0.477-2.3682.720.73-0.9530.541.502-0.1530.989-1.642-1.9150.291-0.1830.9940.0371.95-2.2251.355-1.037
Other Working Capital -1.7424.532-3.8143.016-21.5686.328-2.533-0.17-1.8233.531-3.972-0.447-0.9512.57329.9560.121-0.382-0.154-0.66
Other Non Cash Items -1.2114.4972.6258.0680.6660.169-1.253-1.4391.855-0.191-0.809-2.4262.4031.4910.695.366-0.08-7.50.425
Operating Cash Flow -32.661-32.866-37.203-21.379-28.788-15.185-27.939-25.044-22.376-21.873-21.673-21.389-14.967-16.47620.313-8.076-8.691-7.205-9.243
Investing Activities:
Investments In Property Plant And Equipment -0.673-2.241-1.448-2.277-4.752-2.553-2.031-2.057-1.654-2.62-0.723-0.685-1.93-0.484-0.022-0.6-0.014-0.053-0.648
Acquisitions Net 00029.19763.724-13.617-22.7340.30.311.353000000000
Purchases Of Investments -97.178-84.235-71.184-84.192-175.892-58.743-75.931-86.511-70.806-71.062-110.684-173.2760000000
Sales Maturities Of Investments 120.664107.80197.08854.995112.16872.3698.66589.73864.12159.70939.300000007.668
Other Investing Activites 3.708-0.125-1.5-29.197-63.72413.61722.734-0.3-0.3-11.353-71.384-173.276-100-0.5730.0107.243
Investing Cash Flow 26.52121.222.956-31.474-68.47611.06420.7031.17-8.339-13.973-72.107-173.961-1.93-0.484-0.022-0.6-0.004-0.0537.02
Financing Activities:
Debt Repayment 00000000000001.15-0.119-0.028-0.0271.55-0.03
Common Stock Issued 0.2440.66911.329-0.113134.37517.3351.1232.1330.6540.3620.99321.02322.683-0.544109.7990000
Common Stock Repurchased 0000000000000000000
Dividends Paid 0000000000000000000
Other Financing Activities 0-0.5371.1560.070.7530.2360.5190.1270.6540.3620.990.46322.683-0.952109.7990.110.1390.0210
Financing Cash Flow 0.2440.13212.485-0.043135.12817.5711.6420.1270.6540.3620.990.46322.6830.606109.680.0820.1121.571-0.03
Other Information:
Effect Of Forex Changes On Cash 000000000.046-0.046000000000
Net Change In Cash -5.896-11.534-1.762-52.89637.86413.45-5.594-23.747-30.015-35.53-92.79-194.89305.786-16.354129.971-8.594-8.583-5.687-2.253
Cash At End Of Period 32.01637.86649.451.162104.10466.2452.7958.38482.131112.146147.676240.466435.356129.57145.92415.95324.54733.1338.817